Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-4-5
pubmed:abstractText
To establish a more efficient treatment for immunotherapy against solid tumors, we have evaluated the antitumor effect by coexpression of a chemokine CCL21/secondary lymphoid tissue chemokine and a costimulatory molecule LIGHT in colon carcinoma C26. C26 cells expressing either CCL21 or LIGHT exhibited a significantly reduced tumor growth in vivo, and mice inoculated with these cells showed a prolonged survival, but eventually all these mice died. In contrast, C26 cells expressing both CCL21 and LIGHT exhibited a minimal tumor growth in vivo, and all these mice survived healthily with a tumor remission and consequently acquired a strong protective immunity. A markedly increased infiltration of mature dendritic cells (DCs), and CD8(+) T cells was observed in the tumor mass, and their spleen cells showed a greatly enhanced cytotoxic T lymphocyte (CTL) activity against C26 tumor and interferon (IFN)-gamma production. Neutralization of IFN-gamma or depletion of CD8(+) or CD4(+) T cells significantly reduced the antitumor activity. These results suggest that the combined treatment with CCL21 and LIGHT is able to induce a synergistic antitumor effect to eradicate tumor completely by greatly enhancing tumor-infiltration of lymphocytes including mature DCs and CD8(+) T cells, resulting in markedly augmented CTL activity and IFN-gamma production.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/CCL21 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Ccl21c protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL21, http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CC, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/TNFSF14 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Tnfsf14 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor Ligand..., http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0929-1903
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
280-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:15002032-Animals, pubmed-meshheading:15002032-CD4-Positive T-Lymphocytes, pubmed-meshheading:15002032-CD8-Positive T-Lymphocytes, pubmed-meshheading:15002032-Carcinoma, pubmed-meshheading:15002032-Cell Line, Tumor, pubmed-meshheading:15002032-Chemokine CCL21, pubmed-meshheading:15002032-Chemokines, CC, pubmed-meshheading:15002032-Chemotaxis, Leukocyte, pubmed-meshheading:15002032-Colonic Neoplasms, pubmed-meshheading:15002032-Dendritic Cells, pubmed-meshheading:15002032-Female, pubmed-meshheading:15002032-Gene Expression, pubmed-meshheading:15002032-Humans, pubmed-meshheading:15002032-Interferon-gamma, pubmed-meshheading:15002032-Membrane Proteins, pubmed-meshheading:15002032-Mice, pubmed-meshheading:15002032-Mice, Inbred BALB C, pubmed-meshheading:15002032-Neoplasm Transplantation, pubmed-meshheading:15002032-Neoplasms, Experimental, pubmed-meshheading:15002032-RNA, Messenger, pubmed-meshheading:15002032-Survival Rate, pubmed-meshheading:15002032-Transfection, pubmed-meshheading:15002032-Tumor Necrosis Factor Ligand Superfamily Member 14, pubmed-meshheading:15002032-Tumor Necrosis Factor-alpha
pubmed:year
2004
pubmed:articleTitle
Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.
pubmed:affiliation
Intractable Immune System Disease Research Center, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't